China Yongxin Pharmaceuticals, Inc. (fka CYXN)

[Bobwins]

Q4 was pretty healthy at .055eps( using higher share count). So if they can maintain that pace in 2010, you are looking at fwd eps of .22. Pretty cheap vs .62.

Retail drug distribution is the key. Chinese government is changing distribution away from hospitals to retail pharmacies. Establishing branded retail chains in big population centers will be the key to profits from drugs that the government is covering.

These are very small drug stores but should grow in sales and profits over time.

Bfar.ob is similar but CFO just left and they replaced CPA firm so question marks there.